Korbet Stephen M, Gashti Casey N, Evans Joni K, Whittier William L
Section of Nephrology, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
Clin Kidney J. 2018 Oct;11(5):610-615. doi: 10.1093/ckj/sfy048. Epub 2018 Jul 2.
Percutaneous renal biopsy (PRB) of native kidneys (NKs) to better understand and treat acute kidney injury (AKI) is being advocated, but little is known about the risk of complications.
We performed a retrospective study of PRB of NKs in 955 adults from 1991 to 2015 at an academic medical center with real-time ultrasound and automated biopsy needles. Patients undergoing PRB for evaluation of AKI ( = 160) were compared with 795 patients biopsied for other reasons (not-AKI) for postbiopsy complications [need for transfusion of packed red blood cells (PRBCs), an interventional radiologic or surgical procedure, readmission or death].
Patients biopsied for AKI were older (58 ± 16 versus 44 ± 16 years; P < 0.0001), with a higher serum creatinine (SCr) (4.5 ± 2.7 versus 1.8 ± 1.6 mg/dL; P < 0.0001) and lower hemoglobin (Hgb) (10.4 ± 1.7 versus 12.1 ± 2.1; P < 0.0001) and a greater proportion had an abnormal bleeding time (12.5% versus 7.4%, P 0.04), partial thromboplastin time (15.2% versus 5.3%, P < 0.0001) and/or prothrombin time (27.0% versus 12.8%; P < 0.0001) compared with not-AKI patients. Complications post-PRB were significantly greater in patients biopsied for AKI {11.3% versus 6.7%; P=0.04; odds ratio [OR] 1.78 [95% confidence interval (CI) 1.01-3.12]} with patients biopsied for AKI requiring more blood transfusions (10.0% versus 5.3%; P 0.02; OR 2.04 (95% CI 1.12-3.74)]. By multivariate analysis, baseline features predictive of a complication were increased SCr and decreased Hgb level, as well as female gender and increased systolic blood pressure.
Patients biopsied for evaluation of AKI are at greater risk of complications due to increased risk factors.
为了更好地理解和治疗急性肾损伤(AKI),经皮肾穿刺活检(PRB)用于天然肾(NK)的做法正在得到提倡,但对于并发症的风险却知之甚少。
我们对1991年至2015年间在一家学术医疗中心接受天然肾PRB的955名成年人进行了一项回顾性研究,采用实时超声和自动活检针。将因评估AKI而接受PRB的患者(n = 160)与795名因其他原因接受活检的患者(非AKI)进行比较,以观察活检后并发症情况[是否需要输注浓缩红细胞(PRBC)、是否需要介入放射学或外科手术、再次入院或死亡]。
因AKI接受活检的患者年龄更大(58±16岁对44±16岁;P < 0.0001),血清肌酐(SCr)更高(4.5±2.7对1.8±1.6mg/dL;P < 0.0001),血红蛋白(Hgb)更低(10.4±1.7对12.1±2.1;P < 0.0001),并且与非AKI患者相比,有更大比例的患者出血时间异常(12.5%对7.4%,P = 0.04)、部分凝血活酶时间异常(15.2%对5.3%,P < 0.0001)和/或凝血酶原时间异常(27.0%对12.8%;P < 0.0001)。因AKI接受活检的患者PRB后并发症明显更多{11.3%对6.7%;P = 0.04;优势比[OR]1.78[95%置信区间(CI)1.01 - 3.12]},因AKI接受活检的患者需要更多输血(10.0%对5.3%;P = 0.02;OR 2.04(95%CI 1.12 - 3.74)]。通过多变量分析,预测并发症的基线特征包括SCr升高、Hgb水平降低、女性性别以及收缩压升高。
因评估AKI而接受活检的患者由于危险因素增加,发生并发症的风险更高。